Physician
Radiation Oncology
Dr. Sunil Krishnan, MD
|
|
Give Review
Sunil Krishnan is an expert in the field of Radiation Oncology. He went to medical school at Christian Medical College Vellore. Doctor Sunil Krishnan, MD is a published doctor. He published 49 publications, including: 'Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative Che...' Sunil Krishnan accepts Medicare.
Publications
- Quantitative investigation of physical factors contributing to gold nanoparticle-mediated proton dose enhancement.
- Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?
- Everything Old Is New Again: Using Nelfinavir to Radiosensitize Rectal Cancer.
- PDL1 Regulation by p53 via miR-34.
- In Reply to Sahadevan.
- Technology for Innovation in Radiation Oncology.
- Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response A...
- Minibeam Therapy With Protons and Light Ions: Physical Feasibility and Potential to Reduce Radiation Side Effects and to Facilitate Hypofractionation.
- Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancer.
- Targeted gold nanoparticles enhance sensitization of prostate tumors to megavoltage radiation therapy in vivo.
- Zerumbone increases oxidative stress in a thiol-dependent ROS-independent manner to increase DNA damage and sensitize colorectal cancer cells to radiation.
- Design of an Yb-169 source optimized for gold nanoparticle-aided radiation therapy.
- Combining Radiation and Immunotherapy: A New Systemic Therapy for Solid Tumors?
- Definitive Chemoradiation for Squamous Cell Carcinoma of the Rectum.
- The rare cancer network: ongoing studies and future strategy.
- Development and Validation of Insulin-like Growth Factor-1 Score to Assess Hepatic Reserve in Hepatocellular Carcinoma.
- Intraoperative radiation therapy for locally advanced primary and recurrent colorectal cancer: Ten-year institutional experience.
- Gold nanoparticles in breast cancer treatment: Promise and potential pitfalls.
- Preoperative Radiation Therapy With Concurrent Capecitabine, Bevacizumab, and Erlotinib for Rectal Cancer: A Phase 1 Trial.
- Intensifying local radiotherapy for pancreatic cancer-who benefits and how do we select them?
- Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after ...
- Targeting pancreatic cancer with magneto-fluorescent theranostic gold nanoshells.
- Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer.
- KRAS Mutations and Rectal Cancer Response to Chemoradiation: Are We Closer to Personalization of Therapy?
- Opportunities and Challenges in the Era of Molecularly Targeted Agents and Radiation Therapy.
- Intensity-modulated Radiation Therapy With Concurrent Chemotherapy for Anal Cancer: Outcomes and Toxicity.
- Metformin use and improved response to therapy in rectal cancer.
- Duodenal Toxicity After Fractionated Chemoradiation for Unresectable Pancreatic Cancer.
- Zyflamend suppresses growth and sensitizes human pancreatic tumors to gemcitabine in an orthotopic mouse model through modulation of multiple targets.
- Ursolic Acid Inhibits Growth and Metastasis of Human Colorectal Cancer in an Orthotopic Nude Mouse Model by Targeting Multiple Cell Signaling Pathways: Chemosensitizat...
- Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy.
- Localized Gastric Cancer Treated with Chemoradation without Surgery: UTMD Anderson Cancer Center Experience.
- Boswellic acid inhibits growth and metastasis of human colorectal cancer in orthotopic mouse model by downregulating inflammatory, proliferative, invasive and angiogen...
- Development and validation of a sensitive LC/MS/MS method for the determination of γ-tocotrienol in rat plasma: application to pharmacokinetic studies.
- Neoadjuvant Treatment Response As an Early Response Indicator for Patients With Rectal Cancer.
- Narrow band imaging of squamous cell carcinoma tumors using topically delivered anti-EGFR antibody conjugated gold nanorods.
- In vivo tumor targeting of gold nanoparticles: effect of particle type and dosing strategy.
- Intensity-modulated radiation therapy for the treatment of squamous cell anal cancer with para-aortic nodal involvement.
- Temporal patterns of fatigue predict pathologic response in patients treated with preoperative chemoradiation therapy for rectal cancer.
- Sacral insufficiency fractures after preoperative chemoradiation for rectal cancer: incidence, risk factors, and clinical course.
- Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma.
- Frequent loss of heterozygosity of chromosome 1q in esophageal adenocarcinoma: loss of chromosome 1q21.3 is associated with shorter overall survival.
- Modification of the cysteine residues in IkappaBalpha kinase and NF-kappaB (p65) by xanthohumol leads to suppression of NF-kappaB-regulated gene products and potentiat...
- Attempted salvage resection for recurrent gastric or gastroesophageal cancer.
- Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group...
- Extrahepatic bile duct adenocarcinoma: patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival ...
- Gastric bleeding after radiation therapy for intrahepatic cholangiocarcinoma.
- Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative Che...
Doctors Specialties
- Internal Medicine
- Radiation Oncology
Accepted Insurances
- Choice Plus POS II
- Amerihealth
- Blue Card PPO
- Blue Choice
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Coventry Health Care
- Choice Care PPO
- Medicare MCR
- MHealth Insured
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Education
-
Mayo School of Graduate Medical Education -
Geisinger Health System -
Christian Medical College Vellore
Hospital
-
University of Texas M.D. Anderson Cancer Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1316046261 |
| Last Name Of The Provider | KRISHNAN |
| First Name Of The Provider | SUNIL |
| View All |
Similar Doctors
|
|
Dr. Nalinakshi S. Rangala, MD |
|
|
Dr. Moshe H. Maor, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Tse-Kuan Yu, MD |
|
|
Dr. Adam S. Garden, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Gregory Chronowski, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Seungtaek Choi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deborah A. Kuban, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Eric L. Chang, MD |
|
|
Dr. James D. Cox, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gary B. Gunn, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Zhongxing Liao, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Bouthaina S. Dabaja, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth S. Bloom, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pavan M. Jhaveri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chad Tang, MD |
|
Dr. Adan A. Rios, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas L. Baxter III, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Arthur D. Hamberger, MD
This Doctor is OpenDoctor Recommended.
|